论文部分内容阅读
胶质瘤是最常见的脑原发肿瘤,其侵袭性生长特征导致传统治疗复发率高、预后差,大量研究致力于探索新的治疗手段。近年来,肿瘤分子靶向治疗已日臻成熟,靶向治疗在胶质瘤治疗中的应用初步结果令人振奋。将肿瘤标本进行分子生物学与药物、放疗敏感性研究,结合患者具体情况与分子生物学特征,对各种治疗方法进行优化,寻找最佳个体化综合治疗方案是胶质瘤治疗研究的方向,将为攻克胶质瘤带来希望。
Glioma is the most common primary brain tumor. Its aggressive growth characteristics lead to a high recurrence rate and poor prognosis in traditional treatment. A large number of studies are dedicated to exploring new therapeutic approaches. In recent years, tumor targeted therapy has matured, the initial results of targeted therapy in the treatment of glioma is encouraging. The tumor specimens for molecular biology and drug sensitivity of radiotherapy, combined with the patient’s specific conditions and molecular biology characteristics of various treatment methods to optimize the search for the best individualized comprehensive treatment of glioma treatment research direction, Will overcome the glioma bring hope.